The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 11-17

  Theisen, Michael ^a   Soe, Soe ^b   Oeuvray, Claude ^b   Thomas, Alan W ^c   Vuust, Jens ^b   Danielsen, Steffen ^c   Jepsen, Søren ^a   Druilhe, Pierre ^a,d  

^a STATENS SERUM INSTITUT   (Denmark)

^b INSTITUT PASTEUR   (France)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^d Department of Medical Research ^*  (Myanmar)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTAMIC ACID; IMMUNOGLOBULIN G ANTIBODY; PARASITE ANTIBODY; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN CELL; MEROZOITE; MONOCYTE; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN TARGETING; SCHIZONT;

EID: 0031975242     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.11-17.1998     Document Type: Article

References (29)

1. Anders, R. F. 1986. Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol. 8:529-539.
2. Borre, M. B., M. Dziegiel, B. Hogh, E. Petersen, K. Ricncck, E. Riley, J. F. Meis, M. Aikawa, K. Nakamura, M. Harada, A. Wind, P. H. Jakobsen, J. Copland, S. Jepsen, N. H. Axelsen, and J. Vuust. 1991. Primary structure and localization of a conserved immunogenic Plasmodium falcipanim gluta-mate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol. Biochem. Parasitol. 49:119-132.
3. Kuttius, E., A. Guanzirolli, J.-F. Trape, C. Regier, L. Konate, and P. Druilhe. 1996. Malaria: even more chronic in nature than previously thought; evidence for submicroscopic parasitaemia detectable by polymerase chain reaction. Trans. R. Soc. Trop. Med. Hyg. 90:15-19.
4. Boudin, C., B. Chumpitazi, M. Dziegiel, F. Peyron, S. Picot, B. Hogh, and P. Ambroise-Thomas. 1993. Possible role of specific immunoglobulin M antibodies to Plasmodium falcipamm antigens in immunoprotection of humans living in hyperendemic area, Burkina Faso. J. Clin. Microbiol. 31:636-641.
5. Bouharoun-Tayoun, H., P. Attanah, A. Sabcharcon, T. Chongsuphajaisiddhi, and P. Druilhe. 1990. Antibodies that protect humans against Plasmadium falcipamm blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172:1633-1641.
6. Bouharoun-Tajoun, H., and P. Druilhe. 1992. P. falciparum malaria: evidence for an isotype imbalance which may be responsible for the delayed acquisition of protective immunity. Infect. Immun. 60:1473-1481.
7. Bouharoun-Tayoun, H., C. Oeuvray, F. Lunel, and P. Druilhe. 1995. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 182:409-418.
8. Brahimi, K., J.-L. Pérignon, M. Bossus, H. Gras, A. Tartar, and P. Druilhe. 1993. Fast immunopurification of small amounts of specific antibodies on peptides bound to ELISA plates. J. Immunol. Methods 162:69-75.
9. Cohen, S., A. McGregor, and S. Carrington. 1961. Gamma globulin and acquired immunity to human malaria. Nature 192:733-737.
10. Druilhe, P., and S. Khusmith. 1987. Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status. Infect. Immun. 55:888-891.
11. Druilhe, P., and J. L. Pérignon. 1994. Mechanisms of defense against P. falciparum asexual blood stages in humans. Immunol. Lett. 41:115-120.
12. Dziegiel, M., M. B. Borre, S. Jepsen, B. Högh, E. Petersen, and J. Vuust. 1991. Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 44:306-313.
13. Dziegiel, M., P. Rowe, S. Bennett, S. J. Allen, O. Olerup, A. Gottschau, M. Borre, and E. M. Riley. 1993. Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect. Immun. 61:103-108.
14. Hoffman, S. L., R. J. Wistar, W. R. Ballou, M. R. Hollingdale, R. A. Wirtz, I. Schneider, H. A. Marwoto, and W. T. Hockmeyer. 1986. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falcipamm. N. Erigl. J. Med. 315:601-606.
15. Hogh, B., E. Petersen, M. Dziegiel, K. H. A. David, M. Borre, A. Holm, J. Vuvst, and S. Jepsen. 1992. Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. Am. J. Trop. Med. Hyg. 46:307-313.
16. Jepsen, S. 1983. Inhibition of in vitro growth of Plasmodium falciparum by purified antimalarial human IgG antibodies. Isolation of target antigens from culture supernatant. Scand. J. Immunol. 18:567-561.
17. Khusmith, S., and P. Druilhe. 1983. Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum. Infect. Immun. 41:219-223.
18. Londono, J. A., H. Gras-Masse, C. Dubeaux, A. Tartar, and P. Druilhe. 1990. Secondary structure and immunogenicity of hybrid synthetic peptides derived from two Plasmodium falciparum pre-erythrocytic antigens. J. Immunol. 145:1557-1563.
19. Lunel, F., and P. Druilhe. 1989. Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparym blood stages in vitro. Infect. Immun. 57:2043-2049.
20. Marsh, K. 1992. Malaria - a neglected disease. Parasitology 104:S53-S69.
21. MeColl, D. J., A. Silva, M. Foley, J. F. Kun, J. M. Favaloro, J. K. Thomson, V. M. Marshall, R. L. Coppel, D. J. Kemp, and R. F. Anders. 1994. Molecular variation in a novel polymorphic antigen associated with Plasmodium falcipamm mcrozoites. Mol. Biochem. Parasitol. 68:53-67.
22. Merrifield, R. B. 1963. Solid-phase peptide synthesis. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149-2152.
23. Oeuvray, C., H. Bouharoun-Tayoun, H. Gras-Masse, E. Bottius, T. Kaidoh, M. Aikawa, M.-C. Filgueim, A. Tartar, and P. Druilhe. 1994. MSP-3: a malaria protein inducing antibodies which promote Plasmodium falciparum killing in cooperation with blood monocytes. Blood 84:1594-1602.
24. Reese, R. T., S. G. Langreth, and W. Trager. 1979. Isolation of stages of the human parasite Plasmodium falcipamm from culture and from animal blood. Bull. W. H. O. 53-67.
25. Roper, C., I. M. Elhassan, L. Hviid, H. Giha, W. Richardson, H. Babiker, G. Satti, T. G. Theander, and D. E. Arnot. 1996. Detection of very low level plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan. Am. J. Trop. Mcd. Hyg. 54:325-331.
26. Sergent, E. D., and L. Parrot. 1935. L'immunité, la prémunition et la résistance innée. Arch. Inst. Pasteur Alger. 23:279-319.
27. Theisen, M., G. Cox, B. Hogh, S. Jepsen, and J. Vuust. 1994. Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus. Infect. Immun. 62:3270-3275.
28. Theisen, M., J. Vuust, A. Gottschau, S. Jepsen, and B. Hogh. 1995. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falcipanim expressed in Escherichia coll. Clin. Diagn. Lab. Immunol. 2:30-34.
29. Trapc, J.-F., C. Regier, L. Konate, N. Diagne, H. Bouganali, B. Canque, F. Lcgros, A. Badji, G. Ndiaye, P. Ndiaje, K. Brahimi, O. Faye, P. Druilhe, and L. Pereira da Silva. 1994. The Dielrno project. A longitudinal study of natural malaria infection in a community living in a holoendemic area of Senegal. Am. J. Trop. Med. Hyg. 51:123-137.